|
ISRCTN
|
ISRCTN73797340
|
|
ClinicalTrials.gov identifier
|
|
|
Public title
|
A randomised study of oral versus intravenous chemotherapy in poor prognosis small cell lung cancer (SCLC)
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
TR9SCLC
|
|
Study hypothesis
|
Not provided at time of registration
|
|
Lay summary
|
Not provided at time of registration
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised controlled trial
|
|
Countries of recruitment
|
United Kingdom
|
|
Disease/condition/study domain
|
Lung (small cell)
|
|
Participants - inclusion criteria
|
1. Histologically or cytologically proven SCLC
2. Patients with extensive disease and poor prognosis, ie Eastern Cooperative Oncology Group (ECOG) performance 2 or 3 or alkaline phosphatase >1.5 upper limit normal range
3. Patients 75 years and over, whatever stage of disease, deemed fit for randomisation
4. No previous malignancy, except non melanomatous skin cancer in the preceding 3 years
5. No medical contraindications to treatment
6. Adequate renal function
|
|
Participants - exclusion criteria
|
Not provided at time of registration
|
|
Anticipated start date
|
01/01/1997
|
|
Anticipated end date
|
31/12/2000
|
|
Status of trial
|
Stopped |
|
Patient information material
|
Not available in web format, please use the contact details below to request a patient information sheet
|
|
Target number of participants
|
Not provided at time of registration
|
|
Interventions
|
1. Regimen A: Chemotherapy, oral etoposide repeated every 3 weeks for six courses.
2. Regimen B: Multi-drug chemotherapy, CAV (cyclophosphamide, adriamycin, vincristine) alternating every 3 weeks with PE (etoposide, cisplatin). A total of six courses, three with each drug combination.
|
|
Primary outcome measure(s)
|
Not provided at time of registration
|
|
Secondary outcome measure(s)
|
Not provided at time of registration
|
|
Sources of funding
|
Not available
|
|
Trial website
|
|
|
Publications
|
1. 1996 interim results in http://www.ncbi.nlm.nih.gov/pubmed/8774567
|
|
Contact name
|
Dr
-
-
|
|
Address
|
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
|
|
City/town
|
London
|
|
Zip/Postcode
|
NW1 2DA
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0) 207 670 4723
|
|
Fax
|
+44 (0) 207 670 4818
|
|
Email
|
|
|
Sponsor
|
UK Co-ordinating Committee for Cancer Research (UKCCCR)
|
|
Address
|
MRC Clinical Trials Unit
222 Euston Road
|
|
City/town
|
London
|
|
Zip/Postcode
|
NW1 2DA
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0) 20 7670 4723
|
|
Fax
|
+44 (0) 20 7670 4818
|
|
Email
|
|
|
Date applied
|
01/07/2001
|
|
Last edited
|
02/02/2012
|
|
Date ISRCTN assigned
|
01/07/2001
|
